Neos Therapeutics
FDA Approved Drugs

Neos Therapeutics

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 6
  • Latest Approval Date Jan 27, 2016
  • Data Source FDA
  • First Approval Date Jan 27, 2016
Company Overview

Company

Neos Therapeutics

Country

U.S.A

Website

Visit Website

Email

BD@neostx.com

Social Profiles

Company Snapshot

Neos Therapeutics

Neos Therapeutics, Inc (Headquarters)2940 N. Hwy 360Grand Prairie, TX 75050

U.S.A

www.neostx.com/ BD@neostx.com View on Map
FDA Approved Drug Records ( 6 records )
2016
27 Jan
RX Application: 204326

Drug Name

ADZENYS XR-ODT

Product Number

1

Dosage Form

-

Strength

EQ 3.1MG BASE

Approval Date

2016-01-27

204326 / 1

Active Ingredient

AMPHETAMINE

Application Number

204326

Product Number

1

Dosage Form

-

Strength

EQ 3.1MG BASE

Approval Date

2016-01-27

Regulatory Status

RX

2016
27 Jan
RX Application: 204326

Drug Name

ADZENYS XR-ODT

Product Number

2

Dosage Form

-

Strength

EQ 6.3MG BASE

Approval Date

2016-01-27

204326 / 2

Active Ingredient

AMPHETAMINE

Application Number

204326

Product Number

2

Dosage Form

-

Strength

EQ 6.3MG BASE

Approval Date

2016-01-27

Regulatory Status

RX

2016
27 Jan
RX Application: 204326

Drug Name

ADZENYS XR-ODT

Product Number

3

Dosage Form

-

Strength

EQ 9.4MG BASE

Approval Date

2016-01-27

204326 / 3

Active Ingredient

AMPHETAMINE

Application Number

204326

Product Number

3

Dosage Form

-

Strength

EQ 9.4MG BASE

Approval Date

2016-01-27

Regulatory Status

RX

2016
27 Jan
RX Application: 204326

Drug Name

ADZENYS XR-ODT

Product Number

4

Dosage Form

-

Strength

EQ 12.5MG BASE

Approval Date

2016-01-27

204326 / 4

Active Ingredient

AMPHETAMINE

Application Number

204326

Product Number

4

Dosage Form

-

Strength

EQ 12.5MG BASE

Approval Date

2016-01-27

Regulatory Status

RX

2016
27 Jan
RX Application: 204326

Drug Name

ADZENYS XR-ODT

Product Number

5

Dosage Form

-

Strength

EQ 15.7MG BASE

Approval Date

2016-01-27

204326 / 5

Active Ingredient

AMPHETAMINE

Application Number

204326

Product Number

5

Dosage Form

-

Strength

EQ 15.7MG BASE

Approval Date

2016-01-27

Regulatory Status

RX

2016
27 Jan
RX Application: 204326

Drug Name

ADZENYS XR-ODT

Product Number

6

Dosage Form

-

Strength

EQ 18.8MG BASE

Approval Date

2016-01-27

204326 / 6

Active Ingredient

AMPHETAMINE

Application Number

204326

Product Number

6

Dosage Form

-

Strength

EQ 18.8MG BASE

Approval Date

2016-01-27

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    6 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
6 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ADZENYS XR-ODT

Application Number

204326

Product Number

1

Active Ingredient

AMPHETAMINE

Dosage Form

-

Strength

EQ 3.1MG BASE

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit